You are viewing: Asia Pacific ECMO Machines Market analysis
Part of: ECMO Machines Market (Global)

The Asia Pacific ECMO Machines Market was valued at $14.51 Million in 2025 and projected to reach to $20.28 Million by 2030, representing a compound annual growth rate of 6.9%. The Asia Pacific ECMO machines market is positioned for significant growth through 2030, driven by expanding healthcare infrastructure and increasing prevalence of life-threatening cardiac and respiratory conditions.

Asia Pacific ECMO Machines Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Asia Pacific ECMO Machines Market Trends and Insights

  • Rest Of Asia Pacific represents a critical emerging market for extracorporeal membrane oxygenation technology, driven by increasing healthcare infrastructure investments and rising prevalence of cardiac and respiratory conditions.
  • The region's CAGR of 6.9% outpaces global growth, reflecting accelerating adoption of advanced life support systems across hospitals and specialized cardiac centers. Rest Of Asia Pacific's market expansion is supported by growing awareness of ECMO therapy benefits, improving reimbursement policies, and rising patient volumes requiring critical care interventions.
  • Healthcare providers in Rest Of Asia Pacific are increasingly recognizing ECMO as a vital therapeutic option for severe cardiopulmonary failure cases.
  • Between 2025 and 2030, Rest Of Asia Pacific is expected to witness significant capital investments in medical device infrastructure, positioning the region as a high-growth opportunity for ECMO machine manufacturers and healthcare stakeholders..

Key Market Statistics

  • CAGR (2025-2030) 6.9% CAGR
  • Market Size, 2025 ~USD 14.51 Million
  • Forecast, 2030 ~USD 20.28 Million
  • Geography Asia Pacific

Asia Pacific ECMO Machines Market Overview

Rapid Market Expansion :

Asia Pacific ECMO machines market is projected to grow from USD 14.51 million in 2025 to USD 20.28 million by 2030, representing a robust 6.9% CAGR, outpacing the global average of 5.8%.

Healthcare Infrastructure Investment :

Increasing government and private sector investments in healthcare infrastructure across Asia Pacific nations are driving adoption of advanced ECMO technology in critical care units and cardiac centers.

Rising Disease Prevalence :

Growing incidence of cardiac and respiratory conditions, coupled with aging populations in developed Asia Pacific markets, is creating sustained demand for extracorporeal membrane oxygenation solutions.

Emerging Market Opportunities :

Rest of Asia Pacific represents a critical emerging market with untapped potential, as developing nations expand their intensive care capabilities and adopt advanced life support technologies.

Asia Pacific ECMO Machines Market Dynamics

  • Key markets including China, India, Japan, and Australia are investing heavily in critical care capabilities, creating substantial opportunities for ECMO technology adoption.
  • The region's 6.9% CAGR reflects strong demand dynamics and improving healthcare accessibility. Government initiatives to enhance emergency medical services, rising healthcare expenditure, and growing awareness of ECMO benefits among medical professionals are accelerating market penetration.
  • Additionally, partnerships between international ECMO manufacturers and regional healthcare providers are facilitating technology transfer and localized solutions, further supporting market expansion across Asia Pacific through the forecast period..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • JOHNSON & JOHNSON

    Key Takeaways

    • Rest Of Asia Pacific ECMO machines market valued at USD 14.51 million in 2025, expanding to USD 20.28 million by 2030
    • Rest Of Asia Pacific demonstrates 6.9% CAGR, outpacing global average growth rate of 5.8%
    • Rest Of Asia Pacific's growth driven by rising cardiac/respiratory disease prevalence and healthcare infrastructure modernization
    • Rest Of Asia Pacific represents high-potential emerging market for ECMO device manufacturers through 2030

    ECMO Machines Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) (Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 5.8% from 2025 to 2030
    Largest Segment ADULT PATIENTS (Patient Type)
    Market Size Base Year (Billions) ~USD 0.65 (2025)
    Revenue Forecast (Billions) ~USD 0.86 (2030)
    Segments Covered Product, Type, Modality, Patient Type, Application, End User

    Asia Pacific ECMO Machines Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Components
    • Machines

    By Type

    • Accessories
    • Cannulas
    • Controllers
    • Oxygenators
    • Pumps

    By Modality

    • Arteriovenous Ecmo
    • Venoarterial Ecmo
    • Venovenous Ecmo

    By Patient Type

    • Adult Patients
    • Neonates
    • Pediatric Patients

    By Application

    • Cardiac Applications
    • Extracorporeal Cardiopulmonary Resuscitation (Ecpr)
    • Respiratory Applications

    By End User

    • Academic & Research Institutions
    • Hospitals
    • Specialty Clinics

    Target Audience

    • ECMO Device Manufacturers : Manufacturers need Asia Pacific market intelligence to identify growth opportunities, assess competitive threats, and develop localized strategies for expanding ECMO device sales across the region.
    • Healthcare Providers & Hospitals : Hospital administrators and critical care directors require market data to justify ECMO technology investments, benchmark against peer institutions, and plan critical care capacity expansion.
    • Medical Device Distributors : Regional distributors and medical device companies need detailed market insights to evaluate partnership opportunities, forecast demand, and optimize inventory management for ECMO equipment.
    • Healthcare Investors & PE Firms : Investment professionals require comprehensive market analysis to identify attractive investment opportunities in ECMO technology companies, healthcare providers, and related infrastructure projects.
    • Government & Healthcare Policy Makers : Policy makers and healthcare administrators need market data to inform healthcare infrastructure planning, technology adoption initiatives, and critical care capacity development strategies.

    Key Companies in the Asia Pacific ECMO Machines Market

    CompanyHQOwnershipStrongest segments
    GETINGESwedenPublic CompanyAcute Care Therapies,Surgical Workflows,Life Science,
    MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),
    TERUMO CORPORATIONJapanPublic CompanyCardiac and Vascular Company,Medical Care Solutions Company,Blood and Cell Technologies Company,
    FRESENIUS MEDICAL CARE AGGermanyPublic CompanyDialysis services (outpatient and in-hospital ESRD/acute),Dialysis machines, cyclers, and water treatment systems,Dialysis consumables and solutions,
    LIVANOVA PLCUnited KingdomPublic CompanyCardiopulmonary (heart-lung machines, oxygenators, autotransfusion, perfusion tubing, cannula, services),Neuromodulation (VNS Therapy for epilepsy and depression, aura6000 development),
    NIPROJapanPublic CompanyDialysis products and artificial organ-related devices,Injection and infusion products, hospital and diabetic products, functional products,Pharmaceutical-Related (CDMO for injectables and oral drugs, kit products),
    WEIGAO GROUP CO., LTD.ChinaPublic CompanyMedical Device Products (infusion, clinical nursing, perioperative, urinary, rehab, extracorporeal circulation),Orthopedic Products (spine, joint, trauma, sports medicine, bone repair, spinal endoscope),Pharma Packaging Products (prefilled systems, packaging consumables, automatic drug delivery),
    ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
    MICROPORT SCIENTIFIC CORPORATIONChinaPublic CompanyCardiovascular Devices,Orthopedics Devices,Cardiac Rhythm Management,

    GETINGE

    Getinge is a Swedish public company founded in 1904 that employs 11,754 people and operates in the medical technology sector.

    MEDTRONIC

    Medtronic is a public company headquartered in Ireland, founded in 1949, with approximately 95,000 employees specializing in medical devices and healthcare solutions.

    TERUMO CORPORATION

    Terumo Corporation is a Japanese public company established in 1921 with 30,591 employees, operating in the medical device and healthcare industry.

    FRESENIUS MEDICAL CARE AG

    Fresenius Medical Care AG is a German public company founded in 1996 with 108,165 employees, providing dialysis and renal care services globally.

    LIVANOVA PLC

    LivaNova PLC is a United Kingdom-based public company founded in 2015 with 3,300 employees, focused on neuromodulation and cardiac surgery solutions.

    NIPRO

    Nipro is a Japanese public company established in 1947 with 38,593 employees, manufacturing medical devices and pharmaceutical products.

    WEIGAO GROUP CO., LTD.

    Weigao Group Co., Ltd. is a Chinese public company founded in 1988 with 13,307 employees, specializing in medical device manufacturing.

    ABBOTT

    Abbott is a United States-based public company founded in 1888 with 115,000 employees, operating across diagnostics, medical devices, nutrition, and pharmaceuticals.

    MICROPORT SCIENTIFIC CORPORATION

    MicroPort Scientific Corporation is a Chinese public company established in 1998 with 6,547 employees, developing and manufacturing medical devices.

    Asia Pacific vs. other regions

    HowAsia Pacific compares to the other 3 regional blocs covered in this market.

    Global
    ~USD 343 Million · 5.6% wtd CAGR ·
    North America
    ~USD 233.7 Million · 5.2% wtd CAGR ·
    Europe
    ~USD 16.93 Million · 7.9% wtd CAGR ·
    Middle East & Africa
    ~USD 65.7 Million · 6% wtd CAGR ·

    Countries within Asia Pacific - compare and drill down

    Country2025 size (native)
    ChinaUSD 39.64 Million
    JapanUSD 19.35 Million
    IndiaUSD 21.36 Million
    South KoreaUSD 12.03 Million
    AustraliaUSD 10.22 Million
    Rest Of Asia PacificUSD 18 Million

    Country market size visualization

    China
    USD 39.64 Million
    Japan
    USD 19.35 Million
    India
    USD 21.36 Million
    South Korea
    USD 12.03 Million
    Australia
    USD 10.22 Million
    Rest Of Asia Pacific
    USD 18 Million

    Reasons to Buy this Report

    • Regional Market Insights : Gain detailed understanding of Asia Pacific ECMO market dynamics, including country-specific growth rates, adoption patterns, and competitive landscapes across emerging and developed markets.
    • Strategic Expansion Planning : Identify high-growth opportunities in China, India, Japan, and Australia to inform market entry strategies and resource allocation decisions for ECMO device manufacturers and distributors.
    • Investment Decision Support : Access comprehensive market sizing and forecasts to support investment decisions, partnership evaluations, and capital allocation for healthcare infrastructure projects in Asia Pacific.
    • Competitive Positioning : Understand regional competitive dynamics, market share distribution, and emerging players to benchmark performance and identify differentiation opportunities in the Asia Pacific ECMO market.
    • Regulatory and Reimbursement Landscape : Leverage insights into country-specific regulatory frameworks, reimbursement policies, and healthcare system structures to optimize product positioning and market access strategies.

    Frequently asked questions

    What is the current market size of ECMO machines in Rest Of Asia Pacific?

    Rest Of Asia Pacific's ECMO machines market is valued at USD 14.51 million in 2025 and is projected to grow to USD 20.28 million by 2030.

    What is the growth rate for ECMO machines in Rest Of Asia Pacific?

    Rest Of Asia Pacific's ECMO machines market is growing at a CAGR of 6.9% from 2025 to 2030, which exceeds the global CAGR of 5.8%.

    What factors are driving ECMO market growth in Rest Of Asia Pacific?

    Rest Of Asia Pacific's ECMO market growth is driven by increasing healthcare infrastructure investments, rising prevalence of cardiac and respiratory diseases, improved reimbursement policies, and growing clinical awareness of ECMO therapy benefits.

    How does Rest Of Asia Pacific compare to the global ECMO market?

    Rest Of Asia Pacific's 6.9% CAGR outpaces the global CAGR of 5.8%, indicating that Rest Of Asia Pacific is a faster-growing region for ECMO machines relative to worldwide market trends.

    What is the forecast market size for ECMO machines in Rest Of Asia Pacific by 2030?

    Rest Of Asia Pacific's ECMO machines market is forecasted to reach USD 20.28 million by 2030, representing a USD 5.77 million increase from the 2025 baseline.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size of the ECMO machines market. Exhaustive secondary research was done to collect information on the ECMO market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the ECMO market.

    Secondary Research

    This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the ECMO market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the ECMO market. Primary sources from the demand side included hospitals, academic & research institutions, specialty clinics, researchers, lab technicians, purchase managers, and stakeholders in corporate & government bodies.

    The following is a breakdown of the primary respondents:

    ECMO Machines Market

    Note 1: C-level primaries include CEOs, COOs, and CTOs.

    Note 2: Others include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the ECMO market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    ECMO Machines Market

    Data Triangulation

    The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of ECMO machines and components. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    An ECMO machine acts as an artificial heart and lung for a patient whose heart or lungs cannot provide enough blood flow or oxygen into the blood. ECMO is used after other methods of supporting the heart and lungs do not work. The goal of ECMO is to let the heart and lungs recover while the patient is supported by the ECMO machine.

    Stakeholders

    • Manufacturers of ECMO Machine Products and Related Devices
    • Suppliers and Distributors of ECMO Machine Devices
    • Hospitals, Clinics, and Medical Colleges
    • Medical Device Procurement Agencies
    • Government Bodies/Municipal Corporations
    • Business Research and Consulting Service Providers
    • Venture Capitalists
    • US Food and Drug Administration (US FDA)
    • European Union (EU)

    Report Objectives

    • To define, describe, and forecast the oxygen concentrators market based on product, modality, patient type, application, end user, and region  
    • To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall oxygen concentrators market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the oxygen concentrators market in six regions, namely, North America (US and Canada), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), the Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), Middle East & Africa, and GCC Countries
    • To strategically profile the key players in the global market and comprehensively analyze their core competencies
    • To track and analyze competitive developments, such as product launches, expansions, agreements, and acquisitions, of the leading players in the market

    Get the Full ECMO Machines Market Report

    Full forecast, segment splits, and company analysis for all ECMO Machines Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status